What Is Newborn G6PD Screening?
Newborn G6PD screening is a simple blood test that measures levels of glucose-6-phosphate dehydrogenase (G6PD), an enzyme found in red blood cells. G6PD helps protect red blood cells from damage caused by certain foods, medications, and infections. When a baby has low or absent G6PD activity, their red blood cells may break down more easily — a process known as haemolysis. Early identification through newborn G6PD screening can help families and healthcare professionals understand a child's enzyme status from the earliest days of life.
For London families — particularly those from communities where G6PD deficiency is more prevalent — understanding this screening option can be an important part of proactive newborn health planning.
Practical Insight: G6PD deficiency is one of the most common enzyme deficiencies worldwide, and awareness of a baby's G6PD status early on may help inform future care decisions made with appropriate healthcare professionals.
Why Does G6PD Deficiency Matter in Newborns?
G6PD deficiency is an inherited condition, passed through the X chromosome. Because of this genetic pattern, it is more commonly observed in males, though females can also be affected or carry the trait.
In newborns, unrecognised G6PD deficiency can sometimes be associated with:
- Neonatal jaundice — which may present more severely in G6PD-deficient babies
- Unexpected haemolytic episodes — triggered by certain substances or infections later in life
- Prolonged newborn jaundice — that may require further clinical assessment
Identifying G6PD status early does not diagnose illness, but it can provide valuable information. Families who are aware of their baby's enzyme levels can share this information with healthcare professionals, potentially supporting more informed care throughout childhood.
Practical Insight: Knowing a baby's G6PD status may help parents have more informed conversations with their midwife, health visitor, or paediatrician about substances and triggers to be mindful of.
Who Should Consider Newborn G6PD Screening?
While the NHS newborn blood spot screening programme covers several important conditions, G6PD deficiency is not currently part of the routine UK newborn screening panel. This means many families may wish to consider private newborn G6PD screening, particularly if there are relevant family or ethnic background factors.
Newborn G6PD screening may be particularly relevant for families with:
- African, African-Caribbean, or Afro-Caribbean heritage
- Mediterranean ancestry (Greek, Italian, Turkish, Middle Eastern)
- South Asian or South-East Asian backgrounds
- A known family history of G6PD deficiency
- Previous children who experienced unexplained neonatal jaundice
- Parents who are known carriers of the G6PD gene variant
London is one of the most ethnically diverse cities in the world. Many London families come from backgrounds where G6PD deficiency prevalence is higher than the UK average, making awareness and access to screening especially relevant in the capital.
Practical Insight: If you are unsure whether your family background may be associated with a higher likelihood of G6PD deficiency, discussing this with a midwife or seeking further information from a healthcare professional can be a helpful starting point.
NHS Newborn Screening vs Private G6PD Screening: A Comparison
Understanding the difference between what the NHS newborn blood spot test covers and what private G6PD screening offers can help London families make informed decisions.
| Feature | NHS Newborn Blood Spot Test | Private Newborn G6PD Screening |
|---|---|---|
| Conditions covered | 9 conditions (e.g., sickle cell, CF, CHT) | G6PD enzyme activity specifically |
| G6PD included? | No — not part of routine screening | Yes — targeted G6PD assessment |
| Timing | Day 5 after birth (heel prick) | Can be arranged at a convenient time |
| Availability | Offered to all UK newborns | Available through private clinics |
| Waiting time | Results within 6–8 weeks | Turnaround times may vary by provider |
| Cost | Free (NHS-funded) | Fee applies — check with your chosen clinic |
| Location | Hospital or community midwife | Walk-in or appointment-based clinic |
Both pathways serve important but different purposes. The NHS blood spot test is an essential universal screening programme. Private G6PD screening can complement this by providing specific enzyme-level information that is not currently captured through the standard NHS panel.
For families in London looking for accessible blood testing services, a walk-in clinic setting can offer a convenient and straightforward experience.
Practical Insight: Private screening does not replace the NHS newborn blood spot test — it may be considered as an additional, complementary assessment for families who wish to understand their baby's G6PD status.
How Is the G6PD Test Performed?
The G6PD screening test is a blood test. In newborns, a small sample of blood is typically collected from the heel (similar to the NHS heel prick) or from a vein, depending on the baby's age and the testing protocol used.
The process generally involves:
- Sample collection — A trained nurse collects a small blood sample
- Laboratory analysis — The sample is sent to an accredited laboratory to measure G6PD enzyme activity
- Results reporting — Results are returned to the family, typically within a few working days depending on the laboratory
At Walk-In Clinic London, our nurse-led team provides testing and reporting services. We do not offer diagnosis, prescriptions, or treatment — but we can help you obtain the screening results you need to share with your medical team.
Practical Insight: If you are considering G6PD screening for your newborn, it can be helpful to confirm the sample collection method and expected turnaround time with your chosen clinic before your appointment.
Understanding G6PD Test Results
G6PD screening results typically report the level of enzyme activity in the blood. Results generally fall into the following categories:
- Normal G6PD activity — Enzyme levels are within the expected range, suggesting typical G6PD function
- Intermediate G6PD activity — Enzyme levels are below the typical range but not severely deficient; this pattern can sometimes be seen in female carriers
- Deficient G6PD activity — Enzyme levels are significantly below the expected range, which may indicate G6PD deficiency
It is important to understand that a screening result alone does not constitute a clinical diagnosis. Results should always be reviewed and interpreted by an appropriate healthcare professional who can consider the full clinical picture, including family history and any symptoms.
If your baby's results suggest low G6PD activity, seeking medical advice from your GP, paediatrician, or haematologist is the recommended next step. They can provide guidance on what the result may mean and any precautions that could be relevant.
Practical Insight: Keeping a record of your baby's G6PD screening result can be valuable — this information may be useful for future healthcare consultations, particularly if your child is ever prescribed medication or requires medical attention.
How Often Should G6PD Screening Be Considered?
G6PD deficiency is a lifelong genetic condition, so the enzyme level identified in a screening test generally reflects a stable characteristic. In most cases:
- A single screening test in the newborn period is typically sufficient to identify G6PD status
- Repeat testing may sometimes be recommended by a healthcare professional if the initial result was borderline or if the sample was collected during a period of acute illness
- Confirmatory testing — In some cases, a follow-up quantitative G6PD assay may be advised by a specialist
For families who are planning future pregnancies, understanding the G6PD status of existing children — and potentially the carrier status of parents — can sometimes be informative. Health screening services at our London clinic are available for individuals who wish to explore relevant blood tests.
Practical Insight: G6PD enzyme levels do not typically change over time, so a single well-timed test in the newborn period can often provide long-term information.
Why London Families Are Increasingly Seeking Private Screening
London's extraordinary cultural diversity means that many families have heritage links to regions where G6PD deficiency is more common. With the condition not currently included in the NHS standard newborn screening panel, there is growing awareness among London parents about the availability of private testing options.
Several factors are contributing to this trend:
- Increased health literacy — Parents are more informed about inherited conditions and proactive screening
- Diverse communities — London boroughs such as Lambeth, Newham, Hackney, Brent, and Tower Hamlets have significant populations from high-prevalence backgrounds
- Accessibility of walk-in services — Nurse-led clinics across London provide convenient access to private blood tests without the need for a GP referral
- Desire for early information — Many parents prefer to have complete health information available as early as possible
Understanding your options and accessing reliable screening can be an empowering step. For those interested in exploring what testing is available, our well woman and well man health checks may also be of interest for broader family health awareness.
Frequently Asked Questions About Newborn G6PD Screening
What is G6PD deficiency in newborns?
G6PD deficiency is an inherited enzyme deficiency that affects red blood cells. In newborns, it can sometimes be associated with more pronounced neonatal jaundice. Newborn G6PD screening identifies whether a baby has reduced enzyme activity, helping families share this information with healthcare professionals for ongoing care.
Is newborn G6PD screening part of the NHS heel prick test?
No, G6PD deficiency is not currently included in the NHS newborn blood spot screening programme in England. Families who wish to know their baby's G6PD status may consider arranging private screening through a clinic that offers this specific blood test.
Who is most at risk of G6PD deficiency?
G6PD deficiency is more common among individuals of African, Mediterranean, Middle Eastern, and South-East Asian descent. Males are more frequently affected due to the X-linked inheritance pattern. Families with a known history of G6PD deficiency may also wish to consider screening.
When is the best time to screen a newborn for G6PD deficiency?
Newborn G6PD screening can generally be performed from a few days after birth. Some healthcare professionals may recommend waiting until after any acute neonatal illness has resolved, as this can occasionally affect results. Your clinic or healthcare provider can advise on optimal timing.
How is the G6PD blood test different from the standard newborn screening?
The NHS newborn blood spot screens for nine specific conditions such as sickle cell disease and cystic fibrosis. A G6PD blood test specifically measures the activity of the G6PD enzyme, providing targeted information about this particular enzyme deficiency that is not captured by the standard panel.
Can newborn G6PD screening diagnose G6PD deficiency?
Screening results can indicate whether G6PD enzyme activity is within the normal range, intermediate, or deficient. However, a screening result should be reviewed by an appropriate healthcare professional for clinical interpretation. Our clinic provides testing and reporting only.
What happens if my baby's G6PD levels are low?
If screening results suggest low G6PD activity, it is advisable to share this information with your baby's GP or paediatrician. They can provide guidance on what the result may mean, including any substances or medications that may be best avoided. Seeking medical advice is the recommended next step.
Is the G6PD test safe for newborns?
The blood test involves collecting a small sample, either from the heel or a vein. It is a routine procedure performed by trained healthcare professionals. As with any blood collection, there may be minor, temporary discomfort, but the procedure is generally well-tolerated.
Can I get newborn G6PD screening at a walk-in clinic in London?
Yes, some walk-in clinics in London offer G6PD blood testing. At Walk-In Clinic London, our nurse-led team can facilitate the blood sample collection and provide your results. We offer testing and reporting — results should then be discussed with your medical team.
How much does private G6PD screening cost in London?
Pricing for G6PD screening may vary by provider. For accurate and up-to-date information on test availability and pricing, please visit the Walk-In Clinic London website or contact the clinic directly.
Taking a Proactive Step for Your Baby's Health
Understanding your baby's G6PD status is a straightforward yet potentially meaningful part of early health awareness. For London families — especially those from communities where G6PD deficiency is more commonly seen — newborn G6PD screening offers an opportunity to gather valuable health information early on.
At Walk-In Clinic London, we provide nurse-led blood testing and screening services in a welcoming, accessible environment. We offer testing and result reporting to help you take informed next steps with your healthcare team.
If you would like to learn more about the screening options available to your family, you are welcome to visit our clinic or explore our website for further information.
Medical Disclaimer
This article is for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Walk In Clinic London provides testing and reporting services only.
Written Date: 21 March 2026
Next Review Date: 21 March 2027
